Search

151. CMS Innovation Center: model implementation and center performance : report to Congressional requesters

Publication:

Washington, DC : United States Government Accountability Office, March 2018

Subject(s):

Diffusion of Innovation
Medicaid
Medicare
Health Care Reform
United States
United States.
Centers for Medicare & Medicaid Services (U.S.)

152. CMS can do more to leverage Medicare claims data to identify unreported incidents of potential abuse or neglect

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2023

Subject(s):

Child Abuse -- legislation & jurisprudence
Elder Abuse -- legislation & jurisprudence
Government Regulation
Medicare -- statistics & numerical data
Vulnerable Populations -- legislation & jurisprudence
United States
Centers for Medicare & Medicaid Services (U.S.)

153. CMS could improve the data it uses to monitor antipsychotic drugs in nursing homes

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, May 2021

Subject(s):

Antipsychotic Agents -- standards
Frail Elderly -- statistics & numerical data
Government Regulation
Nursing Homes -- legislation & jurisprudence
Vulnerable Populations -- legislation & jurisprudence
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

154. CMS did not detect some inappropriate claims for durable medical equipment in nursing facilities

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2018

Subject(s):

Durable Medical Equipment -- economics
Insurance, Health, Reimbursement
Medicare -- economics
Skilled Nursing Facilities
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

155. CMS has opportunities to strengthen states’ oversight of Medicaid Managed Care Plans’ reporting of medical loss ratios

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022

Subject(s):

Government Regulation
Managed Care Programs -- organization & administration
Medicaid
State Health Planning and Development Agencies
United States
Centers for Medicare & Medicaid Services (U.S.)

156. CMS should bolster its oversight of manufacturer-submitted average sales price data to ensure accurate Part B drug payments

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, December 2022

Subject(s):

Cost Control
Drug Costs
Drug Industry
Government Regulation
Medicare Part B
Prescription Fees
United States
Centers for Medicare & Medicaid Services (U.S.)

157. CMS should pursue strategies to increase the number of at-risk beneficiaries acquiring naloxone through Medicaid

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2020

Subject(s):

Government Regulation
Medicaid -- economics
Naloxone -- supply & distribution
Opioid-Related Disorders -- economics
United States
United States. Department of Health and Human Services

158. CMS should take further action to address states with poor performance in conducting nursing home surveys

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, January 2022

Subject(s):

Government Regulation
Health Care Surveys -- standards
Nursing Homes -- legislation & jurisprudence
Public Reporting of Healthcare Data
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

159. CMS use of data on nursing home staffing: progress and opportunities to do more

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, March 2021

Subject(s):

Government Regulation
Health Workforce -- legislation & jurisprudence
Nursing Homes -- standards
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

160. CMS validated hospital inpatient quality reporting program data, but should use additional tools to identify gaming

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, April 2017

Subject(s):

Economics, Hospital
Insurance, Health, Reimbursement
Quality Indicators, Health Care
Reimbursement, Incentive
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

161. CMS’s encounter data lack essential information that Medicare Advantage organizations have the ability to collect

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, August 2020

Subject(s):

Data Management -- legislation & jurisprudence
Fraud -- prevention & control
Government Regulation
Medicare Part C -- organization & administration
Records -- statistics & numerical data
United States
United States. Department of Health and Human Services

162. COVID-19 Provider Relief Fund: HRSA continues to recover remaining payments due from providers : report to congressional committees

Publication:

Washington, DC : United States Government Accountability Office, September 2023

Subject(s):

COVID-19
Disaster Planning -- economics
Disaster Planning -- organization & administration
Fraud -- prevention & control
Government Regulation
Health Personnel -- economics
Legislation, Medical
United States
United States. Health Resources and Services Administration

163. COVID-19 antivirals utilization: geographic and demographic patterns of treatment in 2022

Author(s):

Murphy, Stephen J. (Stephen James), author
Samson, Lok Wong, author
Sommers, Benjamin D., author

Publication:

Washington, D.C. : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, December 23, 2022

Subject(s):

Antiviral Agents -- therapeutic use
COVID-19 Drug Treatment
Drug Utilization -- statistics & numerical data
State Government
United States

164. COVID-19 cases and deaths, metropolitan and nonmetropolitan counties over time: (update)

Author(s):

Ullrich, Fred, author
Mueller, Keith, author

Publication:

Iowa City, IA : Rural Policy Research Institute, February 2022

Subject(s):

COVID-19 -- epidemiology
COVID-19 -- mortality
Rural Population -- statistics & numerical data
Urban Population -- statistics & numerical data
United States

165. COVID-19 container closure system and component changes: glass vials and stoppers

Publication:

[Silver Spring, MD] : Center for Drug Evaluation and Research, March 2021

Subject(s):

Drug Packaging
Glass
COVID-19
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

166. COVID-19 contracting: Indian Health Service used flexibilities to meet increased medical supply needs : report to congressional addressees

Publication:

Washington, DC : United States Government Accountability Office, October 2021

Subject(s):

American Indian or Alaska Native -- statistics & numerical data
COVID-19 -- ethnology
Equipment and Supplies -- supply & distribution
Government Regulation
United States
United States. Indian Health Service

167. COVID-19 hospitalizations in Pennsylvania: March to June 2020

Publication:

Harrisburg, PA : Pennsylvania Health Care Cost Containment Council, July 2021

Subject(s):

COVID-19 -- epidemiology
Hospitalization -- statistics & numerical data
Hospitalization -- trends
Pennsylvania
United States

168. COVID-19 in nursing homes: CMS needs to continue to strengthen oversight of infection prevention and control : report to congressional addressees

Publication:

Washington, DC : United States Government Accountability Office, September 2022

Subject(s):

COVID-19
Government Regulation
Infection Control -- legislation & jurisprudence
Legislation, Medical
Nursing Homes -- standards
United States
Centers for Medicare & Medicaid Services (U.S.)

169. COVID-19 in nursing homes: Experts identified actions aimed at improving infection prevention and control : report to congressional addressees

Publication:

Washington, DC : United States Government Accountability Office, March 2023

Subject(s):

COVID-19 -- prevention & control
Cross Infection -- prevention & control
Hand Hygiene -- legislation & jurisprudence
Government Regulation
Legislation, Medical
Nursing Homes -- legislation & jurisprudence
United States

170. COVID-19 in nursing homes: HHS has taken steps in response to pandemic, but several GAO recommendations have not been implemented : testimony before the Committee on Finance, U.S. Senate

Publication:

Washington, DC : United States Government Accountability Office, March 17, 2021

Subject(s):

COVID-19 -- economics
Government Regulation
Nursing Homes -- trends
United States

171. COVID-19 in nursing homes: most homes had multiple outbreaks and weeks of sustained transmission from May 2020 through January 2021 : report to Congressional addressees

Publication:

Washington, DC : United States Government Accountability Office, May 2021

Subject(s):

COVID-19 -- epidemiology
Government Regulation
Nursing Homes -- standards
United States
Centers for Medicare & Medicaid Services (U.S.)

172. COVID-19 intensifies nursing home workforce challenges

Author(s):

Denny-Brown, Noelle, author
Stone, Denise, author
Hays, Burke, author
Gallagher, Dayna, author

Publication:

[Washington, D.C.] : United States Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, Office of Behavioral Health, Disability, and Aging Policy October 2020

Subject(s):

COVID-19
Health Workforce
Nursing Homes
Pandemics
United States

173. COVID-19 mortality rates across noncore, micropolitan, and metropolitan counties by community characteristics, December 2020-January 2021

Author(s):

Zahnd, Whitney E., author
Gadag, Khyathi, author
Ullrich, Fred, author
Mueller, Keith J., 1951- author

Publication:

Iowa City, IA : Rural Policy Research Institute, January 2023

Subject(s):

COVID-19 -- mortality
Local Government
Rural Population -- statistics & numerical data
Socioeconomic Factors
State Government
Urban Population -- statistics & numerical data
United States

174. COVID-19 pandemic: VA provides health care assistance to civilians as part of the federal response : report to Congressional addressees

Publication:

Washington, DC : United States Government Accountability Office, May 2021

Subject(s):

COVID-19 -- prevention & control
Disaster Planning -- organization & administration
Government Regulation
United States
United States. Department of Veterans Affairs

175. COVID-19 pandemic: actions needed to improve federal oversight of assistance to individuals, communities, and the transportation industry : testimony before the Committee on Transportation and Infrastructure, House of Representatives

Publication:

Washington, DC : United States Government Accountability Office, July 29, 2021

Subject(s):

COVID-19 -- economics
Disasters -- economics
Government Regulation
United States

176. COVID-19 public health emergency: general considerations for pre-IND meeting requests for COVID-19 related drugs and biological products : guidance for industry and investigators

Publication:

[Silver Spring, MD] : Center for Drug Evaluation and Research, May 2020

Subject(s):

Biological Products
COVID-19 Drug Treatment
Drug Approval
Drug Industry
Drugs, Investigational
Drug Evaluation, Preclinical
Investigational New Drug Application
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

177. COVID-19 public health emergency: policy on COVID-19-related sanitation tunnels : guidance for industry and investigators

Publication:

[Silver Spring, MD] : Center for Drug Evaluation and Research, February 2022

Subject(s):

COVID-19
Disinfection -- standards
Sanitation -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

178. COVID-19 relief bolstered U.S. child care programs in crisis

Author(s):

Smith, Linda, (Of Bipartisan Policy Center's Early Childhood Initiative), author
Bagley, Anubhav, author
Reef, Grace, author
Sarkar, Mousumi, author

Publication:

Washington, D.C. : Bipartisan Policy Center, September 2022

Subject(s):

COVID-19
Child Day Care Centers -- economics
Financing, Government
United States

179. COVID-19 tests drove an increase in total Medicare Part B spending on lab tests in 2020, while use of non-COVID-19 tests decreased significantly

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, December 2021

Subject(s):

Clinical Laboratory Techniques -- economics
COVID-19 Testing -- economics
Government Regulation
Medicare Part B -- economics
United States
United States. Department of Health and Human Services

180. COVID-19 vaccination associated with reductions in COVID-19 mortality and morbidity in the United States, and an approach to valuing these benefits

Author(s):

Holtkamp, Nicholas, author
Kolbe, Allison, author
Beleche, Trinidad, author

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, December 2021

Subject(s):

COVID-19 -- epidemiology
COVID-19 -- mortality
COVID-19 Vaccines -- economics
Hospitalization -- statistics & numerical data
Insurance Coverage
Morbidity
United States

181. COVID-19 vaccine hesitancy and reasons for hesitancy among essential and non-essential workers

Author(s):

Beleche, Trinidad, author
Ross, Tamia, author
Marus, Jessica, author
Karimi, Madjid, author
Grigorescu, Violanda, author

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, March 2023

Subject(s):

Attitude of Health Personnel
COVID-19 Vaccines
Health Behavior
Health Personnel
Patient Acceptance of Health Care
Vaccination Hesitancy -- statistics & numerical data
United States

182. COVID-19. GAO recommendations can help federal agencies better prepare for future public health emergencies

Publication:

Washington, DC : United States Government Accountability Office, July 2023

Subject(s):

Civil Defense -- legislation & jurisprudence
COVID-19
Government Regulation
Legislation, Medical
Public Health Administration -- legislation & jurisprudence
United States Government Agencies
United States

183. COVID-19: Agencies are taking steps to improve future use of Defense Production Act authorities : report to congressional committees

Publication:

Washington, DC : United States Government Accountability Office, December 2021

Subject(s):

Equipment and Supplies -- economics
Government Regulation
Public Health -- legislation & jurisprudence
COVID-19
United States
United States.
United States. Department of Defense

184. COVID-19: Current and future federal preparedness requires fixes to improve health data and address improper payments : report to congressional committees

Publication:

[Washington, DC] : United States Government Accountability Office, April 2022

Subject(s):

COVID-19 -- economics
Fraud -- legislation & jurisprudence
Government Regulation
Pandemics -- legislation & jurisprudence
Routinely Collected Health Data
United States

185. COVID-19: DOD has focused on strategy and oversight to protect military servicemember health : report to Congressional addressees

Publication:

Washington, DC : United States Government Accountability Office, June 2021

Subject(s):

COVID-19 -- prevention & control
Government Regulation
Military Personnel -- legislation & jurisprudence
United States

186. COVID-19: FDA took steps to help make tests available; policy for future public health emergencies needed : report to congressional addressees

Publication:

Washington, DC : United States Government Accountability Office, May 2022

Subject(s):

COVID-19 -- prevention & control
COVID-19 Testing -- standards
Government Regulation
Policy Making
Public Health
United States
United States. Food and Drug Administration

187. COVID-19: Federal efforts to provide vaccines to racial and ethnic groups : report to congressional committees

Publication:

Washington, DC : United States Government Accountability Office, February 2022

Subject(s):

COVID-19 Vaccines -- economics
Government Regulation
Vulnerable Populations -- statistics & numerical data
United States

188. COVID-19: HHS agencies’ planned reviews of vaccine distribution and communication efforts should include stakeholder perspectives : report to congressional committees

Publication:

Washington, DC : United States Government Accountability Office, November 2021

Subject(s):

COVID-19 Vaccines -- supply & distribution
Government Regulation
United States
United States. Department of Health and Human Services

189. COVID-19: HHS and DOD transitioned vaccine responsibilities to HHS, but need to address outstanding issues : report to congressional addressees

Publication:

Washington, DC : United States Government Accountability Office, January 2022

Subject(s):

COVID-19 Vaccines -- supply & distribution
Government Regulation
Health Workforce -- legislation & jurisprudence
United States
United States. Department of Defense
United States. Department of Health and Human Services

190. COVID-19: HHS funds allocated to support disproportionately affected communities : report to congressional addressees

Publication:

Washington, DC : United States Government Accountability Office, January 2023

Subject(s):

COVID-19 -- economics
Disaster Planning -- legislation & jurisprudence
Government Regulation
Legislation, Medical
Pandemics -- economics
Arizona
Louisiana
Michigan
New Hampshire
Washington
United States. Department of Health and Human Services

191. COVID-19: HHS should clarify agency roles for emergency return of U.S. citizens during a pandemic : report to Congressional addressees

Publication:

Washington, DC : United States Government Accountability Office, April 2021

Subject(s):

Disaster Planning -- legislation & jurisprudence
Government Regulation
Travel-Related Illness
United States
United States. Department of Health and Human Services

192. COVID-19: HHS’s collection of hospital capacity data : report to Congressional addressees

Publication:

Washington, DC : United States Government Accountability Office, August 2021

Subject(s):

COVID-19 -- economics
Data Analysis
Government Regulation
Surge Capacity -- legislation & jurisprudence
United States
Centers for Medicare & Medicaid Services (U.S.)

193. COVID-19: Information on HHS's public education campaign : report to congressional committees

Publication:

Washington, DC : United States Government Accountability Office, March 2022

Subject(s):

Education, Public Health Professional
Financial Management -- organization & administration
Government Regulation
Health Promotion -- organization & administration
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
National Institutes of Health (U.S.)

194. COVID-19: Pandemic lessons highlight need for public health situational awareness network : report to congressional addressees

Publication:

Washington, DC : United States Government Accountability Office, June 2022

Subject(s):

Awareness
Civil Defense -- organization & administration
COVID-19
Government Regulation
Pandemics -- legislation & jurisprudence
United States
United States. Department of Health and Human Services

195. COVID-19: Selected states modified meal provision and other Older Americans Act services to prioritize safety : report to congressional addressees

Publication:

Washington, DC : United States Government Accountability Office, December 2021

Subject(s):

Food Services -- economics
Health Services for the Aged -- economics
Home Care Services -- organization & administration
Government Regulation
COVID-19
United States
United States.

196. COVID-19: TSA could better monitor its efforts to reduce infectious disease spread at checkpoints : report to Congressional committees

Publication:

Washington, DC : United States Government Accountability Office, June 2021

Subject(s):

Airports -- legislation & jurisprudence
COVID-19 -- prevention & control
Government Regulation
Travel-Related Illness
United States

197. COVID-19: USAID plans to share lessons learned from efforts to meet global vaccination goal : report to congressional addressees

Publication:

Washington, DC : United States Government Accountability Office, September 2023

Subject(s):

COVID-19 Vaccines -- supply & distribution
Global Health
Government Regulation
Immunization Programs
International Cooperation
Legislation, Medical
United States
United States. Agency for International Development

198. COVID-19: VA should assess its oversight of infection prevention and control in community living centers : report to Congressional addressees

Publication:

Washington, DC : United States Government Accountability Office, July 2021

Subject(s):

Communicable Disease Control -- legislation & jurisprudence
COVID-19 -- economics
Government Regulation
Nursing Homes -- legislation & jurisprudence
United States
United States. Department of Veterans Affairs

199. COVID-19: brief update on initial federal response to the pandemic : report to Congress

Publication:

Washington, DC : United States Government Accountability Office, August 2020

Subject(s):

COVID-19 -- economics
Financing, Government -- organization & administration
Government Regulation
Health Status Indicators
United States

200. COVID-19: continued attention needed to enhance federal preparedness, response, service delivery, and program integrity : report to Congressional committees

Publication:

Washington, DC : United States Government Accountability Office, July 2021

Subject(s):

COVID-19 -- economics
Disasters -- economics
Government Regulation
United States